Search All News
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
New eye drops could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults, a study by Columbia University researchers has found.
Columbia researchers have found hundreds of genes linked to nearsightedness, and now they’re using the data to screen for new drugs that can safeguard sharp vision.
Vagelos student Emery Jamerson’19 received the 2018 Dr. David K. McDonogh Scholarship in Ophthalmology/ENT, named for the first black Columbia-trained doctor in New York.
- November 15, 2018
The most common tests for glaucoma can underestimate the severity of the condition because they do not detect the presence of central vision loss, ophthalmologists at Columbia have found.
- May 4, 2018
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
- May 3, 2018
Neuroscientist Carol Mason, PhD, was elected to the National Academy of Sciences along with 104 other new members and foreign associates.
- September 27, 2017
Columbia Ophthalmology's new tele-ophthalmology van will screen, free of charge, 2,000 NYC residents each year for major sight-threatening conditions.
- August 18, 2017
CUMC ophthalmologist Tongalp Tezel has tips to protect your vision during a solar eclipse, including why taking a selfie with the sun is a bad idea.
- May 30, 2017
Researchers report that CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome.
- April 19, 2017
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
- November 14, 2016
Columbia University researchers slowed vision loss in mice who have a form of retinitis pigmentosa by reprogramming the metabolism of photoreceptors in the retina.